Health systems have made dozens of M&A deals this year, as many are seeking out partnerships to grow and protect their long-term financial sustainability. Here is a rundown of five newsworthy deals announced in 2023.
Javier Gonzalez, Chief Growth and Commercial Officer at Abarca, about why payers are increasingly looking for alternatives to the traditional PBM model. Learn More.
Pitch your startup at INVEST 2024 for a chance to win a $20,000 advertising credit on MedCityNews.com. Select one track from four options (Biopharma, Devices & Diagnostics, Healthtech: Consumer/Employer, Healthtech: Payer/Provider). Each track will feature six finalists. Deadline to apply is February 29, 2024. Finalists will be announced starting March 31, 2024. There is no fee to apply.
The FDA said promethazine hydrochloride, a generic drug used to manage allergies and motion sickness, should be administered by intramuscular injection. Intravenous injection can cause chemical irritation and tissue damage, an FDA alert states.
A new KFF report analyzed recent trends in Medicaid outpatient prescription drug utilization and spending. It discovered that although there's been lower utilization of prescription drugs in recent years, Medicaid spending on prescription drugs has increased.
While the urgency to fill positions might tempt senior care centers to prioritize quantity over quality, this approach risks exacerbating the existing challenges. It is crucial to acknowledge that the senior care industry demands a level of expertise and empathy that goes beyond mere technical competence.
In this episode, Marielle Farina, senior manager of Deloitte, discusses a report she recently co-authored that found that employed women pay significantly more in out-of-pocket medical costs than employed men.
No comments